Ulcerative colitis is diagnosed through a combination of blood tests, stool samples, and a colonoscopy with tissue biopsies. No single test confirms it on its own. Instead, doctors piece together your symptoms, lab results, and what they see inside your colon to reach a diagnosis and rule out other conditions that look similar.
Symptoms That Trigger the Workup
The symptoms that typically lead a doctor to investigate ulcerative colitis are persistent diarrhea, blood in your stool, and abdominal pain. These can range from mild to severe, and they vary quite a bit from person to person. Some people notice urgency (needing to find a bathroom immediately), while others experience fatigue, weight loss, or cramping that comes and goes over weeks.
Your doctor will review your medical and family history during the initial visit, since ulcerative colitis has a genetic component. A physical exam checks for tenderness in the abdomen, signs of anemia like pale skin, and general nutritional status. These steps help determine how urgently you need further testing and whether your symptoms point toward inflammatory bowel disease or something else entirely, like an infection or irritable bowel syndrome.
Blood Tests and Inflammatory Markers
The first round of lab work usually includes a complete blood count (CBC) and tests for inflammation. The CBC can reveal anemia, which is common when the colon is chronically inflamed and bleeding, along with elevated platelet counts that signal ongoing inflammation. These findings aren’t specific to ulcerative colitis, but they help build the picture.
Two inflammation markers, C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), are part of the standard initial workup recommended by the American College of Gastroenterology. Both rise when inflammation is active somewhere in the body. CRP is the more sensitive and specific of the two for detecting active inflammation, but neither test can pinpoint where the inflammation is or confirm that it’s ulcerative colitis. They’re screening tools. If these markers come back elevated alongside your symptoms, the next step is looking directly at your colon.
Stool Tests
Stool samples serve two purposes: ruling out infections and measuring intestinal inflammation. Bacterial infections, parasites, and a particular toxin-producing bacterium called C. difficile can all mimic ulcerative colitis symptoms. These need to be excluded before the diagnosis moves forward.
A stool test called fecal calprotectin measures a protein released by white blood cells in the gut lining. Higher levels indicate active intestinal inflammation. This test is especially useful as a non-invasive way to determine whether symptoms are likely caused by true inflammation or by a functional condition like irritable bowel syndrome, which doesn’t produce elevated calprotectin. It’s also used after diagnosis to monitor for flares. In monitoring studies, levels above roughly 150 micrograms per gram have been associated with a higher chance of relapse within the following two years.
Colonoscopy: The Key Diagnostic Step
A colonoscopy is the most important part of the diagnostic process. It allows a gastroenterologist to directly examine the lining of your entire colon and take tissue samples. You’ll prepare by drinking a bowel-cleansing solution the day before, and the procedure itself is done under sedation, so you won’t feel it.
Ulcerative colitis has a distinctive visual pattern. The inflammation always starts in the rectum and extends upward in a continuous line with no gaps of healthy tissue. This is one of the clearest ways to distinguish it from Crohn’s disease, which can affect any part of the digestive tract and often skips areas, leaving patches of normal tissue between inflamed segments.
Early in the disease, the colon lining appears red, finely granular, and fragile, bleeding easily when touched. The normal network of tiny blood vessels visible through healthy tissue disappears. In more severe cases, the doctor may see large ulcers with pus, and sometimes small mound-like projections called pseudopolyps, which are islands of swollen or relatively normal tissue surrounded by ulcerated areas.
The initial colonoscopy also establishes the extent of your disease, which is classified using the Montreal system into three categories: proctitis (inflammation limited to about the last 15 centimeters of the rectum), left-sided colitis (extending past the rectum but not beyond the splenic flexure, a bend in the colon near your spleen), or extensive colitis (reaching beyond the splenic flexure, with pancolitis meaning the entire colon is involved). This classification matters because it influences treatment decisions and how often you’ll need surveillance colonoscopies going forward.
Biopsies Confirm the Diagnosis
During the colonoscopy, the doctor takes small tissue samples from multiple spots along the colon. These biopsies are examined under a microscope by a pathologist, and this step is what truly confirms ulcerative colitis.
The microscopic hallmarks include distorted crypt architecture (the tiny tube-shaped glands in the colon lining become irregular and branched), collections of immune cells that have infiltrated the tissue, and crypt abscesses, where immune cells accumulate inside the glands themselves. Pathologists also look for mucin depletion (the protective mucus layer thins out) and damage to the surface lining of the colon. A key feature is that the inflammation is confined to the mucosa and submucosa, the two innermost layers of the colon wall. Crohn’s disease, by contrast, can penetrate through the full thickness of the intestinal wall.
Importantly, biopsies are taken even from areas that look normal during the colonoscopy. Current guidelines recommend sampling the colon above the visible border of inflammation because microscopic inflammation can extend further than what the eye can see. This hidden extension can change how the disease is classified and managed. In children especially, 5 to 30 percent of cases show patchy microscopic inflammation in the rectum even when it appears normal on camera, so rectal biopsies are taken regardless of how the tissue looks.
Distinguishing Ulcerative Colitis From Crohn’s Disease
Because ulcerative colitis and Crohn’s disease share many symptoms, a major goal of the diagnostic process is telling them apart. The distinction matters because the two conditions behave differently over time and respond to different treatments.
The most reliable differentiators come from the colonoscopy and biopsies. Ulcerative colitis affects only the colon, starts in the rectum, and spreads in a continuous pattern. Crohn’s can show up anywhere from the mouth to the anus, often appears in patches with healthy bowel in between, and tends to cause deeper inflammation that can lead to fistulas or strictures. Crohn’s may also involve the small intestine, which ulcerative colitis does not.
In a small percentage of cases, the features overlap enough that a definitive distinction isn’t possible right away. These cases are sometimes labeled “indeterminate colitis” until additional information, either from disease behavior over time or further testing, tips the diagnosis one way or the other.
What Happens After Diagnosis
Once ulcerative colitis is confirmed, your doctor uses all the gathered information to determine severity and plan treatment. Severity is assessed by combining your symptoms (how many bowel movements per day, how much blood, how you feel overall) with what the colonoscopy showed. A commonly used benchmark is the endoscopic Mayo score, where a score of 0 or 1 represents mucosal healing, which is now considered a key treatment goal.
You can expect follow-up colonoscopies at intervals determined by the extent and duration of your disease, both to monitor treatment response and to screen for colon cancer, since long-standing ulcerative colitis increases that risk. Between colonoscopies, stool calprotectin tests and blood work offer less invasive ways to track whether inflammation is staying under control or quietly returning.